Clinical evaluation of the effect of glyclopyramide in diabetes mellitus.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002241:Carbohydrates / Q000652:urine; D002747:Chlorpropamide / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D000078790:Insulin Secretion; D008055:Lipids / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010179:Pancreas / Q000378:metabolism; D014044:Tolbutamide / Q000627:therapeutic use
D001786:Blood Glucose; D002241:Carbohydrates; D007004:Hypoglycemic Agents; D007328:Insulin; D008055:Lipids; D002784:Cholesterol; D014044:Tolbutamide; D002747:Chlorpropamide